Table 2.
Variable | Overall Population (N=72 824) | No. (%) of Patientsa | P Value | ||||
---|---|---|---|---|---|---|---|
Isolated CABG (N=52 546) | CABG+Single Valve (N=7936)b | CABG+Multiple Valves (N=665)c | Single Valve (N=10 368)b | Multiple Valves (N=1309)c | |||
Age, mean±SD, y | 67.0±10.2 | 65.9±9.8 | 72.6±9.0 | 72.5±9.1 | 67.5±11.2 | 68.3±11.4 | <0.001 |
40–64 | 28 941 (39.7) | 22 925 (43.6) | 1460 (18.4) | 129 (19.4) | 3969 (38.3) | 458 (35.0) | <0.001 |
65–74 | 25 229 (34.6) | 18 626 (35.4) | 2795 (35.2) | 216 (32.5) | 3197 (30.8) | 395 (30.2) | |
75–84 | 16 806 (23.1) | 10 220 (19.4) | 3128 (39.4) | 269 (40.5) | 2801 (27.0) | 388 (29.6) | |
≥85 | 1848 (2.5) | 775 (1.5) | 553 (7.0) | 51 (7.7) | 401 (3.9) | 68 (5.2) | |
Rural residence | 11 763 (16.2) | 8204 (15.6) | 1457 (18.4) | 143 (21.5) | 1756 (16.9) | 203 (15.5) | |
Income quintile | |||||||
1 (Lowest) | 13 448 (18.5) | 10 003 (19.0) | 1370 (17.3) | 102 (15.3) | 1728 (16.7) | 245 (18.7) | <0.001 |
2 | 14 696 (20.2) | 10 724 (20.4) | 1608 (20.3) | 148 (22.3) | 1959 (18.9) | 257 (19.6) | |
3 | 14 759 (20.3) | 10 627 (20.2) | 1609 (20.3) | 157 (23.6) | 2117 (20.4) | 249 (19.0) | |
4 | 15 017 (20.6) | 10 714 (20.4) | 1705 (21.5) | 127 (19.1) | 2214 (21.4) | 257 (19.6) | |
5 (Highest) | 14 532 (20.0) | 10 184 (19.4) | 1617 (20.4) | 129 (19.4) | 2310 (22.3) | 292 (22.3) | |
Missing | 372 (0.5) | 294 (0.6) | 27 (0.3) | ≤5 | 40 (0.4) | 9 (0.7) | |
Hypertension | 62 852 (86.3) | 46 111 (87.8) | 7185 (90.5) | 595 (89.5) | 7954 (76.7) | 1007 (76.9) | <0.001 |
Atrial fibrillation | 5165 (7.1) | 2373 (4.5) | 990 (12.5) | 155 (23.3) | 1343 (13.0) | 304 (23.2) | <0.001 |
Recent MI | 22 952 (31.5) | 20 684 (39.4) | 1659 (20.9) | 132 (19.8) | 422 (4.1) | 55 (4.2) | <0.001 |
Remote MI | 11 605 (15.9) | 9432 (17.9) | 1295 (16.3) | 108 (16.2) | 679 (6.5) | 91 (7.0) | <0.001 |
Previous PCI | 10 532 (14.5) | 8773 (16.7) | 1004 (12.7) | 68 (10.2) | 617 (6.0) | 70 (5.3) | <0.001 |
Heart failure | 19 847 (27.3) | 10 126 (19.3) | 3714 (46.8) | 430 (64.7) | 4729 (45.6) | 848 (64.8) | <0.001 |
LVEF, % | |||||||
≥50 | 48 185 (66.2) | 32 237 (61.4) | 5630 (70.9) | 435 (65.4) | 8843 (85.3) | 1040 (79.4) | |
35–50 | 15 448 (21.2) | 12 762 (24.3) | 1398 (17.6) | 145 (21.8) | 967 (9.3) | 176 (13.4) | |
20–35 | 6044 (8.3) | 4911 (9.3) | 654 (8.2) | 66 (9.9) | 346 (3.3) | 67 (5.1) | |
<20 | 1113 (1.5) | 905 (1.7) | 139 (1.8) | 13 (2.0) | 43 (0.4) | 13 (1.0) | |
Missing | 2034 (2.8) | 1731 (3.3) | 115 (1.4) | 6 (0.9) | 169 (1.6) | 13 (1.0) | <0.001 |
Cerebrovascular disease | 7420 (10.2) | 5132 (9.8) | 1073 (13.5) | 82 (12.3) | 970 (9.4) | 163 (12.5) | <0.001 |
Peripheral arterial disease | 9139 (12.5) | 6424 (12.2) | 1389 (17.5) | 108 (16.2) | 1079 (10.4) | 139 (10.6) | <0.001 |
COPD or asthma | 21 419 (29.4) | 14 702 (28.0) | 2726 (34.3) | 251 (37.7) | 3301 (31.8) | 439 (33.5) | <0.001 |
Diabetes mellitus | 32 812 (45.1) | 25 267 (48.1) | 3639 (45.9) | 266 (40.0) | 3218 (31.0) | 422 (32.2) | <0.001 |
Morbid obesity | 28 391 (39.0) | 20 490 (39.0) | 3106 (39.1) | 281 (42.3) | 3951 (38.1) | 563 (43.0) | 0.004 |
Hypothyroidism | 1419 (1.9) | 969 (1.8) | 186 (2.3) | 18 (2.7) | 206 (2.0) | 40 (3.1) | <0.001 |
Liver disease | 633 (0.9) | 351 (0.7) | 81 (1.0) | 11 (1.7) | 153 (1.5) | 37 (2.8) | <0.001 |
Anemia | 7347 (10.1) | 4918 (9.4) | 1113 (14.0) | 136 (20.5) | 977 (9.4) | 203 (15.5) | <0.001 |
Venous thromboembolism | 288 (0.4) | 173 (0.3) | 46 (0.6) | ≤5 | 57 (0.5) | 10 (0.8) | <0.001 |
Dialysis | 1531 (2.1) | 1047 (2.0) | 233 (2.9) | 22 (3.3) | 195 (1.9) | 34 (2.6) | <0.001 |
Baseline creatinine, μmol/L | |||||||
120–179 | 6635 (9.1) | 4487 (8.5) | 1037 (13.1) | 93 (14.0) | 855 (8.2) | 163 (12.5) | <0.001 |
<120 | 60 190 (82.7) | 43 934 (83.6) | 6158 (77.6) | 522 (78.5) | 8538 (82.3) | 1038 (79.3) | |
≥180 | 2435 (3.3) | 1698 (3.2) | 381 (4.8) | 32 (4.8) | 261 (2.5) | 63 (4.8) | |
Missing | 3564 (4.9) | 2427 (4.6) | 360 (4.5) | 18 (2.7) | 714 (6.9) | 45 (3.4) | |
Chronic renal disease | 3133 (4.3) | 2109 (4.0) | 516 (6.5) | 43 (6.5) | 399 (3.8) | 66 (5.0) | <0.001 |
Dementia | 176 (0.2) | 98 (0.2) | 41 (0.5) | 6 (0.9) | 27 (0.3) | ≤5 | <0.001 |
Depression | 1089 (1.5) | 733 (1.4) | 149 (1.9) | 13 (2.0) | 157 (1.5) | 37 (2.8) | <0.001 |
Psychosis | 161 (0.2) | 102 (0.2) | 17 (0.2) | ≤5 | 33 (0.3) | 6 (0.5) | 0.025 |
Primary tumor | 3770 (5.2) | 2486 (4.7) | 539 (6.8) | 48 (7.2) | 601 (5.8) | 96 (7.3) | <0.001 |
Metastatic cancer | 375 (0.5) | 248 (0.5) | 40 (0.5) | ≤5 | 72 (0.7) | 10 (0.8) | 0.03 |
Charlson score, median (IQR) | 1 (0–3) | 2 (0–3) | 2 (0–3) | 2 (1–3) | 1 (0–2) | 1 (0–2) | <0.001 |
Frailtyc | 11 685 (16.0) | 8623 (16.4) | 1491 (18.8) | 154 (23.2) | 1204 (11.6) | 213 (16.3) | <0.001 |
CABG indicates coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention.
Unless otherwise stated.
Mitral, aortic, or tricuspid valve surgery.